Size: 0.1mg
Contents: IGF-1 DES
Form: Lyophilized powder
Purity: >99%
IGF-1 DES 0.1mg is a high-purity, research-grade truncated analog of insulin-like growth factor-1 (IGF-1), engineered by removing the first three amino acids of the native peptide. This structural modification significantly reduces binding to IGF-binding proteins, resulting in a highly potent and rapidly acting compound ideal for precise in-vitro and preclinical research applications.
Supplied as a lyophilized powder, IGF-1 DES 0.1mg is widely utilized in studies focused on localized IGF-1 receptor activation, cellular proliferation, and tissue-level anabolic signaling. Its fast-acting profile makes it particularly valuable for experiments requiring short-duration, high-intensity receptor engagement.
IGF-1 DES 0.1mg is recognized in research for its enhanced potency and rapid onset of action compared to full-length IGF-1 and long-acting analogs like IGF-1 LR3. Its reduced affinity for binding proteins allows for greater receptor availability, making it especially effective in localized and time-sensitive experimental models.
Researchers in muscle biology, regenerative medicine, and cellular signaling rely on IGF-1 DES for its ability to stimulate targeted anabolic responses and support satellite cell activation. Its distinct pharmacokinetic profile makes it a complementary tool alongside other IGF-1 analogs in growth factor research.
Peptide Type: Truncated IGF-1 analog
Compound: IGF-1 DES (Des(1-3)IGF-1)
Structure: N-terminal truncated IGF-1 (missing first 3 amino acids)
Primary Function: Localized cellular growth and anabolic signaling research
IGF-1 DES 0.1mg functions by binding to IGF-1 receptors (IGF-1R), initiating intracellular signaling pathways associated with cell growth, proliferation, and differentiation.
Due to its truncated structure, it exhibits minimal interaction with IGF-binding proteins, allowing for rapid and potent receptor activation. This leads to enhanced local signaling effects, making it ideal for studies focused on tissue-specific responses and short-term anabolic activity.
IGF-1 DES 0.1mg is widely utilized in laboratory studies focused on:
Its rapid action and high potency make it an essential compound for targeted and precision-based research.
In controlled research environments, IGF-1 DES has demonstrated strong activity in pathways associated with cellular growth and localized anabolic signaling. Studies suggest that its rapid receptor activation may enhance tissue-specific responses and support precise experimental outcomes.
Ongoing research continues to explore its applications in muscle regeneration, tissue engineering, and growth factor biology, reinforcing its importance in advanced cell and molecular research.
Product Name: IGF-1 DES
Quantity: 0.1mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store IGF-1 DES 0.1mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
IGF-1 DES 0.1mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in compliance with applicable laws and regulations.
